Application Sponsors
ANDA 213342 | ACCORD HLTHCARE | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Prescription | 004 |
Application Products
001 | TABLET;ORAL | 200MG | 0 | HYDROXYCHLOROQUINE SULFATE | HYDROXYCHLOROQUINE SULFATE |
002 | TABLET;ORAL | 100MG | 0 | HYDROXYCHLOROQUINE SULFATE | HYDROXYCHLOROQUINE SULFATE |
003 | TABLET;ORAL | 300MG | 0 | HYDROXYCHLOROQUINE SULFATE | HYDROXYCHLOROQUINE SULFATE |
004 | TABLET;ORAL | 400MG | 0 | HYDROXYCHLOROQUINE SULFATE | HYDROXYCHLOROQUINE SULFATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2020-04-07 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
004 | Prescription | AB |
CDER Filings
ACCORD HLTHCARE
cder:Array
(
[0] => Array
(
[ApplNo] => 213342
[companyName] => ACCORD HLTHCARE
[docInserts] => ["",""]
[products] => [{"drugName":"HYDROXYCHLOROQUINE SULFATE","activeIngredients":"HYDROXYCHLOROQUINE SULFATE","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"04\/07\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2020-04-07
)
)